1Centre de Référence pour les Maladies Rares à expression Psychiatrique, GHU Paris Psychiatrie et Neurosciences, Paris, France
2Department of Child and Adolescent Psychiatry, Pitié-Salpêtrière Hospital, Paris, France
3GRC-15, Dimensional Approach of Child and Adolescent Psychotic Episodes, Faculté de Médecine, Sorbonne Université, Paris, France
4Nutrition Department, Rare Diseases Center of Reference “Prader–Willi Syndrome and Obesity With Eating Disorders” (PRADORT), Assistance Publique-Hôpitaux de Paris, Pitié-Salpêtrière Hospital, INSERM, Nutriomics, Sorbonne Université, Paris, France
5Institute of Psychiatry and Neuroscience of Paris (IPNP), INSERM U1266, Université Paris Cité, Paris, France
6Department of Psychiatry, McGill University, Montréal, QC, Canada
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
✉*Correspondence: Cécile Louveau cecile.louveau@ghu-paris.fr
*Anton Iftimovici anton.iftimovici@inserm.fr
This article was submitted to Neurodevelopment, a section of the journal Frontiers in Neuroscience
Copyright © 2023 Louveau, Turtulici, Consoli, Poitou, Coupaye, Krebs, Chaumette and Iftimovici.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.